Lixte Biotechnology Holdings, Inc. (LIXT) Q1 2026 Annual Earnings
LIXT·Reported May 14, 2026·Before market open
Diluted EPS came in at $-0.18 (+37.9% YoY).
Diluted EPS
$-0.18
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Lixte Biotechnology Holdings, Inc.'s Q1 2026 earnings report.
Lixte Biotechnology Holdings, Inc. (LIXT) reported Q1 2026 earnings on May 14, 2026 before market open.
Lixte Biotechnology Holdings, Inc. reported diluted EPS of $-0.18 for Q1 2026.
Compared to the same quarter a year prior, diluted EPS grew 37.9% from $-0.29.
You can read the 10-K periodic report (0001493152-26-014052) directly on SEC EDGAR. The filing index links above go to sec.gov.